Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial i...
Saved in:
Published in | FEBS open bio Vol. 11; no. 11; pp. 2966 - 2976 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.11.2021
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway.
Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes. |
---|---|
AbstractList | Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe²⁺ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe²⁺ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe 2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe 2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway.Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway. Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe 2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe 2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes. |
Author | Liu, Xiu‐Juan Li, Yan Lv, Yan‐Fei Cui, Wen‐Zhu Liu, Yang Xue, Yi‐Tao Dong, Feng |
AuthorAffiliation | 3 Department of cardiovascular diseases The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China 1 Department of cardiovascular diseases Shandong University of Traditional Chinese Medicine Affiliated Hospital Jinan China 2 Department of Rehabilitation Medicine Shandong Provincial Hospital affiliated to Shandong First Medical University Jinan China |
AuthorAffiliation_xml | – name: 3 Department of cardiovascular diseases The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China – name: 1 Department of cardiovascular diseases Shandong University of Traditional Chinese Medicine Affiliated Hospital Jinan China – name: 2 Department of Rehabilitation Medicine Shandong Provincial Hospital affiliated to Shandong First Medical University Jinan China |
Author_xml | – sequence: 1 givenname: Xiu‐Juan surname: Liu fullname: Liu, Xiu‐Juan organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital – sequence: 2 givenname: Yan‐Fei surname: Lv fullname: Lv, Yan‐Fei organization: Shandong Provincial Hospital affiliated to Shandong First Medical University – sequence: 3 givenname: Wen‐Zhu surname: Cui fullname: Cui, Wen‐Zhu organization: The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine – sequence: 4 givenname: Yan surname: Li fullname: Li, Yan organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital – sequence: 5 givenname: Yang surname: Liu fullname: Liu, Yang organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital – sequence: 6 givenname: Yi‐Tao surname: Xue fullname: Xue, Yi‐Tao organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital – sequence: 7 givenname: Feng orcidid: 0000-0002-2099-8467 surname: Dong fullname: Dong, Feng email: dongfengg0103@163.com organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34407320$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkr1u2zAUhYUiRfPTzN0KAV26OOafKHEp0ARJYyBolnYmKOpSpiGTLikl0Vb0CfqMeZLSdmokGRIuJC7P-chLnsNsz3kHWfYBoxOMEJkSgvGkYJyeYEpK_iY72FX2Hq33s-MYFygNjjBH6F22TxlDJSXoIPsz0ypY63Lr5ra2fczn48rfWTUN4O_GFpzqrXf3v_9a1wwamtxACH7V-2hj7k2e7I31y9HrsYeY31iVB2iHbmNbC_o55N-DIdPL60TBebStU511bb5S_fxWje-zt0Z1EY4f5qPs58X5j7PLydX1t9nZ16uJLkTBJ3VZioppXtVamMKIGmqNjaEMtNGNFsgwVlBWAldYCUwqRaFWTQ2oEVw3hh5lsy238WohV8EuVRilV1ZuCj60UoXe6g5kqROJsRrREjHKUW0QrgSFsgBSgmgS68uWtRrqJTQaXB9U9wT6dMfZuWz9jawKziijCfD5ARD8rwFiL5c2aug65cAPUZISV5RiQfDr0oKTihIuUJJ-eiZd-CGk544y_TYtGBVMvKQihcCCUlatb_jxcYu73v5nJwmmW4EOPsYAZifBSK4DKtcRlOsIyk1Ak6N45tC23wQlvZHtXvDxre_WdjC-doy8OD9lW-M_Tc_6uA |
CitedBy_id | crossref_primary_10_1016_j_lfs_2023_122007 crossref_primary_10_3389_fphar_2022_906073 crossref_primary_10_1016_j_biopha_2023_115432 crossref_primary_10_1016_j_phrs_2024_107281 crossref_primary_10_1371_journal_pone_0302650 crossref_primary_10_31083_j_rcm2505149 crossref_primary_10_2174_0929867330666230223103524 crossref_primary_10_1007_s10495_023_01814_8 crossref_primary_10_1016_j_cellsig_2024_111328 crossref_primary_10_1016_j_tice_2022_101956 crossref_primary_10_1016_j_prmcm_2024_100377 crossref_primary_10_1007_s11033_023_08948_7 crossref_primary_10_4103_apjtb_apjtb_588_23 crossref_primary_10_1186_s12906_024_04463_9 crossref_primary_10_1007_s00011_023_01842_9 crossref_primary_10_12677_acm_2024_1451731 crossref_primary_10_1007_s00210_022_02243_1 crossref_primary_10_1080_1061186X_2022_2085728 crossref_primary_10_1016_j_lfs_2024_122439 crossref_primary_10_3389_fphar_2023_1146651 crossref_primary_10_3390_molecules29092005 crossref_primary_10_1016_j_ejphar_2023_175985 crossref_primary_10_1038_s41416_023_02149_6 crossref_primary_10_1155_2022_3961495 crossref_primary_10_3389_fendo_2024_1366285 crossref_primary_10_3390_antiox13030334 crossref_primary_10_3389_fncel_2024_1475934 crossref_primary_10_3389_fphar_2022_956355 crossref_primary_10_3892_ijmm_2024_5402 crossref_primary_10_3389_fphar_2022_933732 crossref_primary_10_1080_08916934_2023_2290357 crossref_primary_10_3390_ijms241512510 crossref_primary_10_3390_ijms25020897 crossref_primary_10_3389_fpls_2023_1133062 crossref_primary_10_3390_molecules28237929 crossref_primary_10_1007_s13105_023_00945_5 crossref_primary_10_1007_s10557_024_07664_z crossref_primary_10_1155_2022_4918343 crossref_primary_10_1038_s41413_024_00398_6 crossref_primary_10_3389_fphar_2024_1476718 crossref_primary_10_3390_medicina59030420 crossref_primary_10_3892_or_2024_8851 crossref_primary_10_1016_j_phytochem_2023_113841 crossref_primary_10_3389_fphar_2023_1103971 crossref_primary_10_3390_agriculture13122192 crossref_primary_10_1016_j_fct_2024_114926 crossref_primary_10_1016_j_placenta_2024_10_013 crossref_primary_10_1371_journal_pone_0317295 crossref_primary_10_1016_j_tem_2023_10_010 crossref_primary_10_1186_s13018_024_05183_z crossref_primary_10_1016_j_cellsig_2024_111345 crossref_primary_10_1186_s12872_024_04220_3 crossref_primary_10_7717_peerj_14952 crossref_primary_10_3390_cells12071050 crossref_primary_10_3892_etm_2024_12519 crossref_primary_10_1016_j_jep_2024_117941 crossref_primary_10_1016_j_jphotobiol_2024_112991 crossref_primary_10_1002_cbin_11763 crossref_primary_10_1016_j_freeradbiomed_2024_05_012 crossref_primary_10_1080_13880209_2023_2244004 crossref_primary_10_3389_fphar_2022_977062 crossref_primary_10_1007_s00210_022_02262_y crossref_primary_10_3389_fphar_2023_1286718 crossref_primary_10_1002_ptr_8278 crossref_primary_10_3390_antiox11010150 crossref_primary_10_32604_biocell_2022_018530 crossref_primary_10_1016_j_biopha_2023_114706 crossref_primary_10_1111_jcmm_18209 crossref_primary_10_3233_CH_242444 crossref_primary_10_3390_antiox11030583 crossref_primary_10_1002_med_21933 crossref_primary_10_1007_s10571_023_01388_8 crossref_primary_10_1038_s41598_024_67557_x crossref_primary_10_2174_0929867330666221111162905 |
Cites_doi | 10.1007/s11325-020-02091-4 10.1016/j.intimp.2019.05.033 10.1155/2018/3071959 10.21037/apm.2019.11.25 10.1016/j.freeradbiomed.2009.07.035 10.1038/cdd.2015.158 10.1016/j.biopha.2019.109567 10.1016/j.biopha.2017.01.147 10.1016/j.ab.2016.10.021 10.1016/bs.apha.2019.10.004 10.1089/ars.2016.6940 10.1172/JCI62874 10.1016/j.tips.2017.02.005 10.1111/1755-5922.12121 10.13075/mp.5893.00137 10.1016/j.fct.2013.12.006 10.1016/j.biopha.2016.08.016 10.1006/meth.2001.1262 10.24272/j.issn.2095-8137.2020.042 10.1007/s12013-014-0506-3 10.1016/j.lfs.2018.08.059 10.3892/mmr.2020.11114 10.1111/jpi.12503 10.3389/fcell.2020.00559 10.1016/j.cell.2013.12.010 10.3390/ijms140917845 10.3892/etm.2020.9504 10.1016/j.bbrc.2018.03.113 10.1073/pnas.1821022116 10.1016/j.ijbiomac.2018.11.190 10.1161/ATVBAHA.118.311832 10.1155/2017/9743280 10.3892/etm.2014.1598 10.1038/s41586-019-1426-6 10.1016/j.cell.2012.03.042 10.1007/s12013-015-0553-4 10.1007/s12013-015-0669-6 10.1007/s10565-020-09530-8 10.1016/j.redox.2020.101670 10.1146/annurev-pharmtox-011112-140320 10.1155/2017/7018393 10.1089/dna.2019.5097 10.1016/j.bbagen.2017.05.019 10.1016/j.ejphar.2018.08.024 10.1016/j.redox.2019.101107 10.1016/j.tcb.2015.10.014 10.1186/s12974-019-1472-x 10.1038/s41418-019-0299-4 10.3892/mmr.2015.3289 10.1016/j.jacc.2015.02.032 10.1016/j.ahj.2015.08.005 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies – notice: 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM DOA |
DOI | 10.1002/2211-5463.13276 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA Publicly Available Content Database CrossRef MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access (Activated by CARLI) url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | ICA inhibits ferroptosis |
EISSN | 2211-5463 |
EndPage | 2976 |
ExternalDocumentID | oai_doaj_org_article_7c53444b03704360bf01893e75e27e9d PMC8564343 1010022211546313276 34407320 10_1002_2211_5463_13276 FEB413276 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US China Germany |
GeographicLocations_xml | – name: China – name: United States--US – name: Germany |
GrantInformation_xml | – fundername: Study on the mechanism of improving exercise tolerance of heart failure by Yi Qi WenYang herbal medicine based on mitochondrial dynamics funderid: 81774247 – fundername: Study on the mechanism of improving exercise tolerance of heart failure by Yi Qi WenYang herbal medicine based on mitochondrial dynamics grantid: 81774247 |
GroupedDBID | --- --K 0R~ 0SF 1OC 24P 4.4 53G 5VS 8FE 8FH AACTN AAEDT AAEDW AAFTH AAFWJ AAHBH AAHHS AAIKJ AALRI AAXUO AAZKR ABMAC ACCFJ ACCMX ACXQS ADBBV ADEZE ADKYN ADPDF ADRAZ ADVLN ADZMN ADZOD AEEZP AENEX AEQDE AEXQZ AFKRA AGHFR AITUG AIWBW AJBDE AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMRAJ AOIJS AVUZU BBNVY BCNDV BENPR BHPHI CCPQU DIK EBS EJD EMOBN FDB GROUPED_DOAJ HCIFZ HYE HZ~ IAO IGS IHR INH IPNFZ ITC IXB KQ8 LK8 M41 M48 M7P M~E NCXOZ O-L O9- OK1 OVD OVEED PIMPY PROAC R9- RIG ROL RPM SSZ TEORI WIN XH2 AAYWO AAYXX ACVFH ADCNI AEUPX AFPKN AFPUW AIGII AKBMS AKYEP CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AAMMB ABUWG AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO GNUQQ PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM PUEGO |
ID | FETCH-LOGICAL-c5956-b77984c68bc9f5f9bebc1ff34ecfcdc90f445347e6a1a9128a3ebadbe0d96cdf3 |
IEDL.DBID | BENPR |
ISSN | 2211-5463 |
IngestDate | Wed Aug 27 01:30:58 EDT 2025 Thu Aug 21 18:12:19 EDT 2025 Fri Jul 11 18:36:29 EDT 2025 Fri Jul 11 06:09:58 EDT 2025 Wed Aug 13 11:29:55 EDT 2025 Wed Aug 13 04:59:00 EDT 2025 Wed Feb 19 02:25:57 EST 2025 Tue Jul 01 04:41:45 EDT 2025 Thu Apr 24 23:08:07 EDT 2025 Wed Jan 22 16:28:21 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | cardiomyocytes icariin Nrf2/HO-1 pathway ferroptosis oxidative stress hypoxia/reoxygenation |
Language | English |
License | Attribution 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5956-b77984c68bc9f5f9bebc1ff34ecfcdc90f445347e6a1a9128a3ebadbe0d96cdf3 |
Notes | Xiu‐Juan Liu and Yan‐Fei Lv contributed equally to this article ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2099-8467 |
OpenAccessLink | https://www.proquest.com/docview/3203543949?pq-origsite=%requestingapplication% |
PMID | 34407320 |
PQID | 2591933483 |
PQPubID | 4368360 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7c53444b03704360bf01893e75e27e9d pubmedcentral_primary_oai_pubmedcentral_nih_gov_8564343 proquest_miscellaneous_2718331921 proquest_miscellaneous_2562832690 proquest_journals_3203543949 proquest_journals_2591933483 pubmed_primary_34407320 crossref_primary_10_1002_2211_5463_13276 crossref_citationtrail_10_1002_2211_5463_13276 wiley_primary_10_1002_2211_5463_13276_FEB413276 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2021 |
PublicationDateYYYYMMDD | 2021-11-01 |
PublicationDate_xml | – month: 11 year: 2021 text: November 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Amsterdam – name: Hoboken |
PublicationTitle | FEBS open bio |
PublicationTitleAlternate | FEBS Open Bio |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
References | 2009; 47 2021; 21 2015; 73 2015; 72 2017; 88 2015; 33 2017; 1861 2013; 123 2019; 16 2019; 125 2018; 41 2019; 120 2014; 64 2020; 8 2021; 37 2015; 170 2013; 14 2017; 38 2019; 23 2013; 53 2019; 26 2018; 499 2018; 213 2019; 116 2016; 83 2020; 87 2014; 7 2018; 38 2017; 524 2019; 8 2019; 73 2017; 2017 2017; 26 2020; 41 2015; 11 2020; 39 2020; 36 2018; 65 2012; 149 2001; 25 2014; 156 2018; 17 2018; 2018 2015; 66 2015; 65 2020; 24 2018; 838 2020; 22 2016; 26 2016; 23 2019; 572 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 Ren ZH (e_1_2_10_31_1) 2018; 17 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_10_1 e_1_2_10_33_1 Li L (e_1_2_10_26_1) 2018; 41 e_1_2_10_50_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_47_1 |
References_xml | – volume: 65 year: 2018 article-title: Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia‐reperfusion injury publication-title: J Pineal Res – volume: 524 start-page: 13 year: 2017 end-page: 30 article-title: Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges publication-title: Anal Biochem – volume: 26 start-page: 660 year: 2017 end-page: 675 article-title: Lymphocyte communication in myocardial ischemia/reperfusion injury publication-title: Antioxid Redox Signal – volume: 83 start-page: 1089 year: 2016 end-page: 1094 article-title: Icariin attenuated oxidative stress induced‐cardiac apoptosis by mitochondria protection and ERK activation publication-title: Biomed Pharmacother – volume: 39 start-page: 210 year: 2020 end-page: 225 article-title: Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress publication-title: DNA Cell Biol – volume: 7 start-page: 1116 year: 2014 end-page: 1122 article-title: Icariin attenuates angiotensin II‐induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species‐dependent JNK and p38 pathways publication-title: Exp Ther Med – volume: 120 year: 2019 article-title: Icariin modulates carrageenan‐induced acute inflammation through HO‐1/Nrf2 and NF‐kB signaling pathways publication-title: Biomed Pharmacother – volume: 22 start-page: 175 year: 2020 end-page: 184 article-title: Dexmedetomidine alleviated sepsis‐induced myocardial ferroptosis and septic heart injury publication-title: Mol Med Rep – volume: 37 start-page: 51 year: 2021 end-page: 64 article-title: Human umbilical cord blood‐derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice publication-title: Cell Biol Toxicol – volume: 16 start-page: 92 year: 2019 article-title: Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2‐dependent manner publication-title: J Neuroinflammation – volume: 41 start-page: 220 year: 2020 end-page: 230 article-title: The pathological role of ferroptosis in ischemia/reperfusion‐related injury publication-title: Zool Res – volume: 125 start-page: 496 year: 2019 end-page: 502 article-title: Involvement of Nrf2 in myocardial ischemia and reperfusion injury publication-title: Int J Biol Macromol – volume: 149 start-page: 1060 year: 2012 end-page: 1072 article-title: Ferroptosis: an iron‐dependent form of nonapoptotic cell death publication-title: Cell – volume: 499 start-page: 44 year: 2018 end-page: 51 article-title: ENPP2 protects cardiomyocytes from erastin‐induced ferroptosis publication-title: Biochem Biophys Res Commun – volume: 1861 start-page: 1893 year: 2017 end-page: 1900 article-title: Ferroptosis: role of lipid peroxidation, iron and ferritinophagy publication-title: Biochim Biophys Acta Gen Subj – volume: 26 start-page: 2284 year: 2019 end-page: 2299 article-title: Ischemia‐induced ACSL4 activation contributes to ferroptosis‐mediated tissue injury in intestinal ischemia/reperfusion publication-title: Cell Death Differ – volume: 26 start-page: 165 year: 2016 end-page: 176 article-title: Ferroptosis: death by lipid peroxidation publication-title: Trends Cell Biol – volume: 123 start-page: 92 year: 2013 end-page: 100 article-title: Myocardial ischemia‐reperfusion injury: a neglected therapeutic target publication-title: J Clin Invest – volume: 73 start-page: 229 year: 2015 end-page: 235 article-title: Icariin exerts protective effect against myocardial ischemia/reperfusion injury in rats publication-title: Cell Biochem Biophys – volume: 156 start-page: 317 year: 2014 end-page: 331 article-title: Regulation of ferroptotic cancer cell death by GPX4 publication-title: Cell – volume: 8 start-page: 565 year: 2019 end-page: 575 article-title: Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI) publication-title: Ann Palliat Med – volume: 14 start-page: 17845 year: 2013 end-page: 17860 article-title: Icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress publication-title: Int J Mol Sci – volume: 23 start-page: 369 year: 2016 end-page: 379 article-title: Ferroptosis: process and function publication-title: Cell Death Differ – volume: 8 start-page: 559 year: 2020 article-title: Icariin prevents extracellular matrix accumulation and ameliorates experimental diabetic kidney disease by inhibiting oxidative stress via GPER mediated p62‐dependent Keap1 degradation and Nrf2 activation publication-title: Front Cell Dev Biol – volume: 2018 start-page: 3071959 year: 2018 article-title: Effects of dexmedetomidine postconditioning on myocardial ischemia/reperfusion injury in diabetic rats: role of the PI3K/Akt‐dependent signaling pathway publication-title: J Diabetes Res – volume: 73 start-page: 304 year: 2019 end-page: 311 article-title: Icariin targets Nrf2 signaling to inhibit microglia‐mediated neuroinflammation publication-title: Int Immunopharmacol – volume: 25 start-page: 402 year: 2001 end-page: 408 article-title: Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐Delta Delta C(T)) Method publication-title: Methods – volume: 65 start-page: 1454 year: 2015 end-page: 1471 article-title: Evolving therapies for myocardial ischemia/reperfusion injury publication-title: J Am Coll Cardiol – volume: 36 year: 2020 article-title: Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis publication-title: Redox Biol – volume: 170 start-page: 971 year: 2015 end-page: 980 article-title: Reperfusion therapy for acute myocardial infarction: concepts and controversies from inception to acceptance publication-title: Am Heart J – volume: 38 start-page: 489 year: 2017 end-page: 498 article-title: Ferroptosis inhibition: mechanisms and opportunities publication-title: Trends Pharmacol Sci – volume: 33 start-page: 134 year: 2015 end-page: 140 article-title: The cardioprotective effect of icariin on ischemia‐reperfusion injury in isolated rat heart: potential involvement of the PI3K‐Akt signaling pathway publication-title: Cardiovasc Ther – volume: 87 start-page: 179 year: 2020 end-page: 203 article-title: Pharmacological effects of icariin publication-title: Adv Pharmacol – volume: 72 start-page: 589 year: 2015 end-page: 597 article-title: Icariin acts as a potential agent for preventing cardiac ischemia/reperfusion injury publication-title: Cell Biochem Biophys – volume: 88 start-page: 823 year: 2017 end-page: 831 article-title: Icariin prevents hypertension‐induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway publication-title: Biomed Pharmacother – volume: 2017 year: 2017 article-title: NLRP3 inflammasome activation‐mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats publication-title: Oxid Med Cell Longev – volume: 838 start-page: 53 year: 2018 end-page: 59 article-title: Betulinic acid alleviates myocardial hypoxia/reoxygenation injury via inducing Nrf2/HO‐1 and inhibiting p38 and JNK pathways publication-title: Eur J Pharmacol – volume: 47 start-page: 1304 year: 2009 end-page: 1309 article-title: Nrf 2:INrf2 (Keap1) signaling in oxidative stress publication-title: Free Radic Biol Med – volume: 24 start-page: 1767 year: 2020 end-page: 1773 article-title: The role of ferroptosis in chronic intermittent hypoxia‐induced liver injury in rats publication-title: Sleep Breath – volume: 572 start-page: 402 year: 2019 end-page: 406 article-title: Intercellular interaction dictates cancer cell ferroptosis via NF2‐YAP signalling publication-title: Nature – volume: 72 start-page: 865 year: 2015 end-page: 867 article-title: Myocardial infarction: symptoms and treatments publication-title: Cell Biochem Biophys – volume: 116 start-page: 2672 year: 2019 end-page: 2680 article-title: Ferroptosis as a target for protection against cardiomyopathy publication-title: Proc Natl Acad Sci USA – volume: 17 start-page: 3336 year: 2018 end-page: 3343 article-title: Icariin protects against ischemia‐reperfusion injury in H9C2 cells by upregulating heat shock protein 20 publication-title: Mol Med Rep – volume: 213 start-page: 25 year: 2018 end-page: 31 article-title: Relaxin protects cardiomyocytes against hypoxia‐induced damage in in‐vitro conditions: Involvement of Nrf2/HO‐1 signaling pathway publication-title: Life Sci – volume: 53 start-page: 401 year: 2013 end-page: 426 article-title: Role of nrf2 in oxidative stress and toxicity publication-title: Annu Rev Pharmacol Toxicol – volume: 21 start-page: 72 year: 2021 article-title: Icariin enhances cell survival in lipopolysaccharide‐induced synoviocytes by suppressing ferroptosis via the Xc‐/GPX4 axis publication-title: Exp Ther Med – volume: 64 start-page: 307 year: 2014 end-page: 313 article-title: Icaritin attenuates cigarette smoke‐mediated oxidative stress in human lung epithelial cells via activation of PI3K‐AKT and Nrf2 signaling publication-title: Food Chem Toxicol – volume: 38 start-page: 2755 year: 2018 end-page: 2762 article-title: Intravenous heme arginate induces HO‐1 (heme oxygenase‐1) in the human heart publication-title: Arterioscler Thromb Vasc Biol – volume: 41 start-page: 3051 year: 2018 end-page: 3062 article-title: Ferroptosis is associated with oxygen‐glucose deprivation/reoxygenation‐induced Sertoli cell death publication-title: Int J Mol Med – volume: 2017 year: 2017 article-title: Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists publication-title: Mediators Inflamm – volume: 11 start-page: 4327 year: 2015 end-page: 4332 article-title: Icariin protects H9c2 cardiomyocytes from lipopolysaccharide‐induced injury via inhibition of the reactive oxygen species‐dependent c‐Jun N‐terminal kinases/nuclear factor‐kappaB pathway publication-title: Mol Med Rep – volume: 23 year: 2019 article-title: NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis publication-title: Redox Biol – volume: 66 start-page: 393 year: 2015 end-page: 405 article-title: Today's oxidative stress markers publication-title: Med Pr – ident: e_1_2_10_28_1 doi: 10.1007/s11325-020-02091-4 – ident: e_1_2_10_33_1 doi: 10.1016/j.intimp.2019.05.033 – ident: e_1_2_10_37_1 doi: 10.1155/2018/3071959 – ident: e_1_2_10_50_1 doi: 10.21037/apm.2019.11.25 – ident: e_1_2_10_35_1 doi: 10.1016/j.freeradbiomed.2009.07.035 – ident: e_1_2_10_11_1 doi: 10.1038/cdd.2015.158 – ident: e_1_2_10_46_1 doi: 10.1016/j.biopha.2019.109567 – ident: e_1_2_10_32_1 doi: 10.1016/j.biopha.2017.01.147 – ident: e_1_2_10_42_1 doi: 10.1016/j.ab.2016.10.021 – ident: e_1_2_10_44_1 doi: 10.1016/bs.apha.2019.10.004 – ident: e_1_2_10_36_1 doi: 10.1089/ars.2016.6940 – ident: e_1_2_10_3_1 doi: 10.1172/JCI62874 – ident: e_1_2_10_12_1 doi: 10.1016/j.tips.2017.02.005 – ident: e_1_2_10_19_1 doi: 10.1111/1755-5922.12121 – ident: e_1_2_10_43_1 doi: 10.13075/mp.5893.00137 – ident: e_1_2_10_48_1 doi: 10.1016/j.fct.2013.12.006 – ident: e_1_2_10_30_1 doi: 10.1016/j.biopha.2016.08.016 – ident: e_1_2_10_23_1 doi: 10.1006/meth.2001.1262 – ident: e_1_2_10_13_1 doi: 10.24272/j.issn.2095-8137.2020.042 – ident: e_1_2_10_18_1 doi: 10.1007/s12013-014-0506-3 – ident: e_1_2_10_29_1 doi: 10.1016/j.lfs.2018.08.059 – ident: e_1_2_10_52_1 doi: 10.3892/mmr.2020.11114 – ident: e_1_2_10_7_1 doi: 10.1111/jpi.12503 – volume: 41 start-page: 3051 year: 2018 ident: e_1_2_10_26_1 article-title: Ferroptosis is associated with oxygen‐glucose deprivation/reoxygenation‐induced Sertoli cell death publication-title: Int J Mol Med – ident: e_1_2_10_54_1 doi: 10.3389/fcell.2020.00559 – ident: e_1_2_10_39_1 doi: 10.1016/j.cell.2013.12.010 – ident: e_1_2_10_16_1 doi: 10.3390/ijms140917845 – ident: e_1_2_10_45_1 doi: 10.3892/etm.2020.9504 – ident: e_1_2_10_22_1 doi: 10.1016/j.bbrc.2018.03.113 – ident: e_1_2_10_14_1 doi: 10.1073/pnas.1821022116 – ident: e_1_2_10_49_1 doi: 10.1016/j.ijbiomac.2018.11.190 – ident: e_1_2_10_53_1 doi: 10.1161/ATVBAHA.118.311832 – ident: e_1_2_10_8_1 doi: 10.1155/2017/9743280 – ident: e_1_2_10_21_1 doi: 10.3892/etm.2014.1598 – ident: e_1_2_10_38_1 doi: 10.1038/s41586-019-1426-6 – ident: e_1_2_10_10_1 doi: 10.1016/j.cell.2012.03.042 – ident: e_1_2_10_2_1 doi: 10.1007/s12013-015-0553-4 – ident: e_1_2_10_15_1 doi: 10.1007/s12013-015-0669-6 – ident: e_1_2_10_25_1 doi: 10.1007/s10565-020-09530-8 – ident: e_1_2_10_27_1 doi: 10.1016/j.redox.2020.101670 – ident: e_1_2_10_34_1 doi: 10.1146/annurev-pharmtox-011112-140320 – ident: e_1_2_10_6_1 doi: 10.1155/2017/7018393 – ident: e_1_2_10_9_1 doi: 10.1089/dna.2019.5097 – ident: e_1_2_10_24_1 doi: 10.1016/j.bbagen.2017.05.019 – ident: e_1_2_10_20_1 doi: 10.1016/j.ejphar.2018.08.024 – ident: e_1_2_10_51_1 doi: 10.1016/j.redox.2019.101107 – ident: e_1_2_10_41_1 doi: 10.1016/j.tcb.2015.10.014 – ident: e_1_2_10_47_1 doi: 10.1186/s12974-019-1472-x – ident: e_1_2_10_40_1 doi: 10.1038/s41418-019-0299-4 – ident: e_1_2_10_17_1 doi: 10.3892/mmr.2015.3289 – volume: 17 start-page: 3336 year: 2018 ident: e_1_2_10_31_1 article-title: Icariin protects against ischemia‐reperfusion injury in H9C2 cells by upregulating heat shock protein 20 publication-title: Mol Med Rep – ident: e_1_2_10_5_1 doi: 10.1016/j.jacc.2015.02.032 – ident: e_1_2_10_4_1 doi: 10.1016/j.ahj.2015.08.005 |
SSID | ssj0000601600 |
Score | 2.5174093 |
Snippet | Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury... |
SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2966 |
SubjectTerms | Apoptosis Apoptosis - drug effects Bioengineering Blood flow Cardiomyocytes Cell death Cell Hypoxia - drug effects Cell Hypoxia - physiology Cell Line Cell Survival - drug effects Dehydrogenases Endoplasmic reticulum Ferroptosis Flavonoids - metabolism Flavonoids - pharmacology Heart attacks Hypoxia Hypoxia - drug therapy Hypoxia - metabolism hypoxia/reoxygenation icariin Iron Ischemia L-Lactate dehydrogenase lactate dehydrogenase Lactic acid Membranes Myocardial infarction Myocardial Reperfusion Injury - metabolism Myocardium Myocytes, Cardiac - drug effects NF-E2-Related Factor 2 - drug effects NF-E2-Related Factor 2 - metabolism Nrf2/HO‐1 pathway Oxidative stress Oxidative Stress - drug effects Plaques protective effect Proteins Reactive oxygen species Reactive Oxygen Species - metabolism Signal transduction Signal Transduction - drug effects Software viability |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQJSQuiH9SCjISBy7pOrbjJEeKulqQKBcq9Rb5VxsJktXuFpob4gl4Rp6EGSe72hWFXrhFsR3FM2PPN8n4G0Je8dwxxXlIAbzaVPoipKYoXGqVV94jHUj8NPDhTM3O5fuL_GKn1BfmhA30wIPgJoXNhZTSMFEgWzozgWXgY32Re174yuHuCz5vJ5ga9mBkTmMbLh_GJxwinRS5348h_kKGkR03FNn6r4OYf2ZK7iLY6IKm98jdETvSN8M73ye3fPuA3B6qSfYPyY93FgLfpqVNO29Ms17Reb_orhrkgOquerCUqIVf339CHA4adTT45bJbrLtVs6JdoDbmpn7pO9sDAKVfG02XQ6l6GIYdACzSs2Xgk9lHeEpGMflD43l2ioWNv-n-ETmfnn56O0vHEgupzZGBEPRSldKq0tgq5KEy3tgsBCG9DdbZigUpQf6FVzrTFfgyLbzRznjmKmVdEI_JQdu1_imhKojMQPDmA6CcrDBauKCs5K7MlTaqTMjxRuK1HfnHsQzG53pgTuY1qqhGFdVRRQl5vR2wGKg3_t71BFW47Yac2fEGWFI9WlJ9kyUl5GhjAPW4kFc1RIcAcYUsxbXNgjOR4-HiKiEvt82wQvG3i259d4mPUFgPSlXsH30AIgiB3HQJeTKY3HYy8NKwD3MYXewZ495s91vaZh6ZwkH0eHI4IZNotjeJsZ6ensh4dfg_BPqM3OGYARRPbh6Rg_Xy0j8HCLc2L-Jq_Q23_kJG priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NjtMwELZgERIXxD-BBRmJA5e0ie3YzQEhFm1VkHa5UGlvUezYNNJuUtLubnNDPAHPyJMw46SFastyi2JPFHtmPN8k9jeEvGZJEUnGXAjg1YTCKhdqpYrQSCutRToQ_2ng6FhOpuLTSXLypxxQP4GLnakd1pOaNqeD1bf2HTj8255AdMggiQmR1n0AqZWSN8ktCEsKvfSox_rdsoxkatGa3ueq3FZk8gT-u1Dn1c2Tf4NaH5XG98jdHk7S953-75MbtnpAbncFJtuH5MdHA7lwWdGympW6XC7orJ3XqxJpoepVC8bjFfPr-09IzUHJBXW2aer5sl6UC1o7avx21bO2Ni1gUnpR5rTpqteDGHYA_EiPG8eGk8_wlJjifpAcj7hTrHV8mbePyHR8-OXDJOyrLoQmQVJCUFU6EkaOtEld4lJttYmd48IaZwqTRk6IhAtlZR7nKYS3nFudF9pGRSpN4fhjslfVlX1KqHQ81pDPWQfAJ1Y654WTRrBilMhcy1FABusZz0xPSY6VMU6zjkyZZaiiDFWUeRUF5M1GYN6xcfy76wGqcNMNabT9jbr5mvVemSkDIxFCR1whFX-kXRQDgLMqsUzZtAjI_toAsrVpZpAwAurlYsR3NnMW8QTPG6cBebVpBqfFPzF5ZetzfITEElEyja7pA6iBc6SrC8iTzuQ2g4GXhqWZgbTaMsat0W63VOXMk4fD1ONh4oAMvdn-bxqz8eGB8FfPrh_sc3KH4XYff0xzn-wtm3P7AvDaUr_0fvgbMis9cQ priority: 102 providerName: Scholars Portal – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NjtMwELZgERIXxD-BBRmJA5dsE9uxkyOLtipILBxYiVtkOzaNBEmVdGFzQzwBz8iTMOO0gcIC4hbVP4o9M_E37sw3hDxmWZVIxnwM4NXGwikfG6Wq2EonnUM6kHA18PJYLk7Ei7fZNpoQc2FGfojpwg0tI3yv0cC16Wc_SEMZuC4xkrkfgEOl5EVyCRNskT6fidfTNUugGwmJKFP_LcFPwma_zLFzNgUK__Nw5-_hkz_D2nAuza-RqxtASZ-OGnCdXHDNDXJ5LDE53CRfnlvwhuuG1s2yNvW6p8th1Z7VSAzVng2gPkE03z5_BeccxFxR77quXa3bvu5p66kNAasfhtYOgErpx1rTbqxfD8OwAyBIetx5Nlu8gllSihEhGpPcKVY7_qSHW-RkfvTm2SLe1F2IbYa0hCCsIhdW5sYWPvOFccam3nPhrLeVLRIvRMaFclKnuoADTnNndGVcUhXSVp7fJntN27i7hErPUwMenfMAfVJlNK-8tIJVeSa1kXlEDrY7XtoNKTnWxnhfjnTKrEQRlSiiMogoIk-mAauRj-PPXQ9RhFM3JNIOP7Tdu3Jjl6WysBIhTMIVkvEnxicpQDinMseUK6qI7G8VoNxYd1-Cywi4l4ucn9vMWcIzzDguIvJoagazxf9idOPaU5xCYpEoWSR_6QO4gXMkrIvInVHlpsXAS8PHmcFotaOMO6vdbWnqZaAPh63HdOKIzILa_msby_nRoQhP9_57xH1yhWEMUMjd3Cd76-7UPQAQtzYPg5l-B1jCPnY priority: 102 providerName: Wiley-Blackwell |
Title | Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2F2211-5463.13276 https://www.ncbi.nlm.nih.gov/pubmed/34407320 https://www.proquest.com/docview/2591933483 https://www.proquest.com/docview/3203543949 https://www.proquest.com/docview/2562832690 https://www.proquest.com/docview/2718331921 https://pubmed.ncbi.nlm.nih.gov/PMC8564343 https://doaj.org/article/7c53444b03704360bf01893e75e27e9d |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fb9MwELfYJiReEP_JGJWReOAla2I7TvKEKGpVkFYmxKS9RbFjr5Eg6dIOljfEJ-Az8km4c9KyijFeoii2o9h3dn53Pv-OkJcsKgLJmPUBvGpfmNj6Ko4LX0sjjUE6EOcaOJrJ6Yl4fxqd9g63ZR9WuV4T3UJd1Bp95EPOAh7hMc709eLcx6xRuLvap9DYIXuwBCdgfO2NxrPjjxsvi2MbCYI1p0_AhgwsHh854A_BDkOmkSu_I8fafx3U_Dti8iqSdb-iyT1yt8eQ9E0n9PvklqkekNtdVsn2IfnxToMBXFa0rOalKldLOm8X9WWJXFD1ZQsa46Tx6_tPsMdBsgW1pmnqxapelktaW6pdjOqXttYtAFH6tcxp06Wsh2ZYAUAjnTWWDacf4C0hxSCQHM-1U0xw_C1vH5GTyfjT26nfp1rwdYRMhCCfNBFaJkqnNrKpMkqH1nJhtNWFTgMrRMRFbGQe5ikMdc6NygtlgiKVurD8Mdmt6so8JVRaHiow4owFtBPGKueFlVqwIolkrmTikcP1iGe65yHHdBifs45BmWUoogxFlDkReeTVpsGio-D4d9URinBTDbmz3YO6Ocv6qZjFGnoihAp4jPz7gbJBCKjNxJFhsUkLjxysFSDrJ_QyAysRoC4XCb-2-I92euTFphhmKm6_5JWpL_AVEvNCyTS4oQ5ABc6Ro84jTzqV23QGPhrWYwat4y1l3OrtdklVzh1jOAw9niD2yNCp7f-GMZuMR8Ld7d_c2WfkDsMYH3c284DsrpoL8xxA2koNyA4Tx4N-Pg6cqwOuRyL5DV2GPzM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwQviP8EBhgJJF6yprbjNA8IMWjVsq0gtEl7C7Fjr5EgKW3HljfEJ-CT8KH4JNy5SVnFGE97i2LHin3ny--cu98R8pSFWSAZsz6AV-0LE1lfRVHma2mkMUgH4o4GdkdysC_eHoQHa-RnkwuDYZWNTXSGOis1npG3OQt4iGmc8cvJFx-rRuHf1aaExkIttk11DC7b7MXwDcj3GWP93t7rgV9XFfB1iKR78CpxV2jZVTq2oY2VUbpjLRdGW53pOLBChFxERqadNAbznXKj0kyZIIulziyHcS-RdcHBlWmR9a3e6P2H5amOYzcJgoZDKGBtBh6Wj5zzm-D3IbPJqc-fqxJwFrT9O0LzNHJ2n77-dXKtxqz01ULJbpA1U9wklxdVLKtb5PtQg8OdFzQvxrnK5zM6riblSY7cU-VJBRrqpP_r2w_w_0GTMmrNdFpO5uUsn9HSUu1iYj9Xpa4A-NKveUqn5rCuK4YdAKTS0dSy9uAdjNKhGHSSYh49xYLKx2l1m-xfiBDukFZRFuYeodLyjgKn0VhAV51IpTyzUguWdUOZKtn1yGaz4omuec-x_ManZMHYzBIUUYIiSpyIPPJ8-cBkQfnx765bKMJlN-TqdjfK6WFSb_0k0jATIVTAI-T7D5QNOoASTRQaFpk488hGowBJbUBmCXilAK256PIzm__sBo88WTaDZcDfPWlhyiMcQmIdKhkH5_QBaMI5cuJ55O5C5ZaTgZcG-8_g6WhFGVdmu9pS5GPHUA5LjxnLHmk7tf3fMib93pZwV_fPn-xjcmWwt7uT7AxH2w_IVYbxRS4vdIO05tMj8xAA4lw9qnclJR8v2hD8Bq-pfEo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJxAviP8EBhgJJF6yJnbiNA8IUdaqY1AmxKS9ZbFjr5EgKWnHljfEJ-Dz8HH4JNw5aVnFGE97i2LHin2X8--cu98R8pSFmScYMy6AV-UGOjKujKLMVUILrZEOxB4NvBuL0V7wZj_cXyM_F7kwGFa5sInWUGelwjPyLmceDzGNM-6aNixid2v4cvrFxQpS-Kd1UU6jUZEdXR-D-zZ7sb0Fsn7G2HDw8fXIbSsMuCpEAj54rbgXKNGTKjahiaWWyjeGB1oZlanYM0EQ8iDSIvXTGEx5yrVMM6m9LBYqMxzGvUTWI_CKvA5Z7w_Gux-WJzyW6cTzFnxCHusy8LZc5J_fBB8QWU5ObYW2YsBZMPfvaM3TKNpug8Pr5FqLX-mrRuFukDVd3CSXm4qW9S3yfVuB850XNC8mucznMzqpp-VJjjxU5UkN2mo14de3H3mRgVZl1OiqKqfzcpbPaGmosvGxn-tS1QCC6dc8pZU-bGuMYQcArHRcGdYdvYdRfIoBKCnm1FMsrnyc1rfJ3oUI4Q7pFGWh7xEqDPclOJDaANLyI5nyzAgVsKwXilSKnkM2FyueqJYDHUtxfEoa9maWoIgSFFFiReSQ58sHpg39x7-79lGEy27I221vlNVh0pqBJFIwkyCQHo-Q-9-TxvMBMeoo1CzSceaQjYUCJK0xmSXgoQLM5kGPn9n858twyJNlM1gJ_PWTFro8wiEE1qQSsXdOH4ApnCM_nkPuNiq3nAy8NOwFDJ6OVpRxZbarLUU-sWzlsPSYveyQrlXb_y1jMhz0A3t1__zJPiZXwAAkb7fHOw_IVYahRjZFdIN05tWRfghYcS4ftR8lJQcXbQd-A0-ogH8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Icariin+inhibits+hypoxia%2Freoxygenation%E2%80%90induced+ferroptosis+of+cardiomyocytes+via+regulation+of+the+Nrf2%2FHO%E2%80%901+signaling+pathway&rft.jtitle=FEBS+open+bio&rft.au=Liu%2C+Xiu%E2%80%90Juan&rft.au=Lv%2C+Yan%E2%80%90Fei&rft.au=Cui%2C+Wen%E2%80%90Zhu&rft.au=Li%2C+Yan&rft.date=2021-11-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2211-5463&rft.volume=11&rft.issue=11&rft.spage=2966&rft.epage=2976&rft_id=info:doi/10.1002%2F2211-5463.13276&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1010022211546313276 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-5463&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-5463&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-5463&client=summon |